Position in MRK
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$12,863,211
+$3,571,701 QoQ
Shares Held
106,935
+21.1% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.48%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 50.176275307429755.ToString("F0")%
Shared 12.884462523963155.ToString("F0")%
None 36.939262168607094.ToString("F0")%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Derivatives in MRK
reported options exposure · as of Mar 31, 2021CallValue
$132,406
CallShares
1,800
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Savant Capital, LLC holds $182,516,970 across 15 Drug Manufacturers - General names. MRK ranks #4 (7.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
223,783 | $54,701,516 | |
| 2 | LLY |
ELI LILLY & Co
|
52,081 | $47,902,541 | |
| 3 | ABBV |
AbbVie Inc.
|
163,461 | $35,551,132 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
106,935 | $12,863,211 | |
| 5 | AMGN |
Amgen Inc
|
25,466 | $8,960,212 | |
| 6 | PFE |
Pfizer Inc
|
194,065 | $5,449,345 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
77,258 | $4,685,697 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
30,192 | $4,207,859 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,863,211 | 106,935 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $9,291,510 | 88,272 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $7,007,147 | 83,488 | Shares | Sole | 2026-03-04 | |
| 2025-06-30 | $6,510,197 | 82,241 | Shares | Sole | 2026-03-04 | |
| 2025-03-31 | $7,039,787 | 78,429 | Shares | Sole | 2026-03-04 | |
| 2024-12-31 | $15,271,075 | 153,509 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $15,462,102 | 136,158 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $14,118,152 | 114,040 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $15,801,144 | 119,751 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $12,608,053 | 115,649 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $11,531,223 | 112,008 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $12,241,494 | 106,088 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $5,449,295 | 51,220 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $5,130,217 | 46,239 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $3,285,822 | 38,154 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $3,505,304 | 38,448 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $2,791,669 | 34,024 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $2,490,646 | 32,498 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $2,383,841 | 31,738 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,635,003 | 33,882 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $2,478,283 | 33,691 | Shares | Sole | 2021-05-04 | |
| 2021-03-31 | $132,406 | 1,800 | Call | Sole | 2021-05-04 | |
| 2020-12-31 | $2,722,658 | 34,882 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $2,611,818 | 32,998 | Shares | Sole | 2020-11-04 | |
| 2020-06-30 | $2,527,245 | 34,250 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $2,501,062 | 34,067 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||